Global Pentavalent Market Size Study & Forecast, by Type (Sodium Stibogluconate, Meglumine Antimoniate), by Formulation Type (Lyophilized, Liquid), by Application (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2023-2030
Global Pentavalent Market is valued at approximately USD 2.43 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2023-2030. Pentavalent is a kind of vaccine that protects against five different diseases: diphtheria, pertussis (whooping cough), tetanus, hepatitis B, and Haemophilus influenzae type b (Hib). It is called a 'pentavalent' vaccine as it contains five different vaccines in one shot. The Pentavalent Market is expanding because of factors such as increasing government initiatives, increasing number of immunization programs, and rising healthcare expenditure.
Diphtheria results in serious difficulties breathing and eating, as well as the potential for skin ulcers. The three-dose schedule of the pentavalent vaccine protects children from diphtheria diseases; as a result, demand for pentavalent vaccines soared as diphtheria became more common. Thus, the rising prevalence of diphtheria is driving the market growth. For instance, the International Health Regulations (IHR) reporting process recorded an unusually high number of reported cases of diphtheria in 2022, primarily in the months of June and August. According to the World Health Organization, a specialized agency of the United Nations with headquarters in Switzerland. 144 cases of diphtheria have been reported from seven different countries, many of whom were refugees. Among 144 individuals, 44 (31%) were found to have toxigenic diphtheria by laboratory confirmation, 97 (69%) were found to be clinically compatible, and 3 (2%), suspected instances. As a result, the market is expanding because of the increasing occurrence of diphtheria. In addition, increasing strategic initiatives by the key market players and growing R&D spending on pentavalent vaccine development activities is creating lucrative growth in the market. However, the high initial cost of pentavalent development and lack of awareness stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Pentavalent Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players and the region's increasing disease prevalence, and rising investment in research and development activities. Asia Pacific is expected to grow at the highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for vaccine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Sanofi
GlaxoSmithKline PLC.
Bristol-Myers Squibb Company
Maiden Pharmaceuticals Limited
Shandong Xinhua Pharmaceutical Co.,Ltd.
Panacea Biotec Ltd.
Biological E. Ltd.
Novartis AG
Shantha Biotechnics Ltd.
Serum Institute of India Pvt. Ltd.
Recent Developments in the Market:
In December 2022, The United States Food and Drug Administration, a US federal agency of the Department of Health and Human Services, approved Pfizer's Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY in Adolescents), which is indicated for the prevention of meningococcal disease in people aged 10 to 25.
In January 2022, Ardian, a private equity investment firm with headquarters in France, acquired Biofarma Group. Ardian would be able to facilitate the market's further international expansion and consolidation with this acquisition. The Biofarma Group is an Italian business that competes in the market for pentavalent vaccines.
Global Pentavalent Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Type, Formulation Type, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Sodium Stibogluconate
Meglumine Antimoniate
By Type:
Lyophilized
Liquid
By Application:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Diphtheria results in serious difficulties breathing and eating, as well as the potential for skin ulcers. The three-dose schedule of the pentavalent vaccine protects children from diphtheria diseases; as a result, demand for pentavalent vaccines soared as diphtheria became more common. Thus, the rising prevalence of diphtheria is driving the market growth. For instance, the International Health Regulations (IHR) reporting process recorded an unusually high number of reported cases of diphtheria in 2022, primarily in the months of June and August. According to the World Health Organization, a specialized agency of the United Nations with headquarters in Switzerland. 144 cases of diphtheria have been reported from seven different countries, many of whom were refugees. Among 144 individuals, 44 (31%) were found to have toxigenic diphtheria by laboratory confirmation, 97 (69%) were found to be clinically compatible, and 3 (2%), suspected instances. As a result, the market is expanding because of the increasing occurrence of diphtheria. In addition, increasing strategic initiatives by the key market players and growing R&D spending on pentavalent vaccine development activities is creating lucrative growth in the market. However, the high initial cost of pentavalent development and lack of awareness stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Pentavalent Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players and the region's increasing disease prevalence, and rising investment in research and development activities. Asia Pacific is expected to grow at the highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for vaccine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Sanofi
GlaxoSmithKline PLC.
Bristol-Myers Squibb Company
Maiden Pharmaceuticals Limited
Shandong Xinhua Pharmaceutical Co.,Ltd.
Panacea Biotec Ltd.
Biological E. Ltd.
Novartis AG
Shantha Biotechnics Ltd.
Serum Institute of India Pvt. Ltd.
Recent Developments in the Market:
In December 2022, The United States Food and Drug Administration, a US federal agency of the Department of Health and Human Services, approved Pfizer's Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY in Adolescents), which is indicated for the prevention of meningococcal disease in people aged 10 to 25.
In January 2022, Ardian, a private equity investment firm with headquarters in France, acquired Biofarma Group. Ardian would be able to facilitate the market's further international expansion and consolidation with this acquisition. The Biofarma Group is an Italian business that competes in the market for pentavalent vaccines.
Global Pentavalent Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Type, Formulation Type, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Sodium Stibogluconate
Meglumine Antimoniate
By Type:
Lyophilized
Liquid
By Application:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Pentavalent Market, by Region, 2020-2030 (USD Billion)
1.2.2. Pentavalent Market, by Type, 2020-2030 (USD Billion)
1.2.3. Pentavalent Market, by Formulation Type, 2020-2030 (USD Billion)
1.2.4. Pentavalent Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PENTAVALENT MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PENTAVALENT MARKET DYNAMICS
3.1. Pentavalent Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of diphtheria
3.1.1.2. Increasing number of immunization programs
3.1.2. Market Challenges
3.1.2.1. High initial cost of pentavalent development
3.1.2.2. Lack of awareness regarding treatment availability
3.1.3. Market Opportunities
3.1.3.1. Growing R&D spending on pentavalent vaccine development activities
3.1.3.2. Increasing strategic initiatives by the key market players
CHAPTER 4. GLOBAL PENTAVALENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL PENTAVALENT MARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Pentavalent Market by Type, Performance - Potential Analysis
5.3. Global Pentavalent Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Pentavalent Market, Sub Segment Analysis
5.4.1. Sodium Stibogluconate
5.4.2. Meglumine Antimoniate
CHAPTER 6. GLOBAL PENTAVALENT MARKET, BY FORMULATION TYPE
6.1. Market Snapshot
6.2. Global Pentavalent Market by Formulation Type, Performance - Potential Analysis
6.3. Global Pentavalent Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
6.4. Pentavalent Market, Sub Segment Analysis
6.4.1. Lyophilized
6.4.2. Liquid
CHAPTER 7. GLOBAL PENTAVALENT MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Pentavalent Market by Application, Performance - Potential Analysis
7.3. Global Pentavalent Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Pentavalent Market, Sub Segment Analysis
7.4.1. Hospitals Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
CHAPTER 8. GLOBAL PENTAVALENT MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Pentavalent Market, Regional Market Snapshot
8.4. North America Pentavalent Market
8.4.1. U.S. Pentavalent Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Formulation Type breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Pentavalent Market
8.5. Europe Pentavalent Market Snapshot
8.5.1. U.K. Pentavalent Market
8.5.2. Germany Pentavalent Market
8.5.3. France Pentavalent Market
8.5.4. Spain Pentavalent Market
8.5.5. Italy Pentavalent Market
8.5.6. Rest of Europe Pentavalent Market
8.6. Asia-Pacific Pentavalent Market Snapshot
8.6.1. China Pentavalent Market
8.6.2. India Pentavalent Market
8.6.3. Japan Pentavalent Market
8.6.4. Australia Pentavalent Market
8.6.5. South Korea Pentavalent Market
8.6.6. Rest of Asia Pacific Pentavalent Market
8.7. Latin America Pentavalent Market Snapshot
8.7.1. Brazil Pentavalent Market
8.7.2. Mexico Pentavalent Market
8.8. Middle East & Africa Pentavalent Market
8.8.1. Saudi Arabia Pentavalent Market
8.8.2. South Africa Pentavalent Market
8.8.3. Rest of Middle East & Africa Pentavalent Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Sanofi
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. GlaxoSmithKline PLC.
9.3.3. Bristol-Myers Squibb Company
9.3.4. Maiden Pharmaceuticals Limited
9.3.5. Shandong Xinhua Pharmaceutical Co.,Ltd.
9.3.6. Panacea Biotec Ltd.
9.3.7. Biological E. Ltd.
9.3.8. Novartis AG
9.3.9. Shantha Biotechnics Ltd.
9.3.10. Serum Institute of India Pvt. Ltd.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Pentavalent Market, by Region, 2020-2030 (USD Billion)
1.2.2. Pentavalent Market, by Type, 2020-2030 (USD Billion)
1.2.3. Pentavalent Market, by Formulation Type, 2020-2030 (USD Billion)
1.2.4. Pentavalent Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PENTAVALENT MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PENTAVALENT MARKET DYNAMICS
3.1. Pentavalent Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of diphtheria
3.1.1.2. Increasing number of immunization programs
3.1.2. Market Challenges
3.1.2.1. High initial cost of pentavalent development
3.1.2.2. Lack of awareness regarding treatment availability
3.1.3. Market Opportunities
3.1.3.1. Growing R&D spending on pentavalent vaccine development activities
3.1.3.2. Increasing strategic initiatives by the key market players
CHAPTER 4. GLOBAL PENTAVALENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL PENTAVALENT MARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Pentavalent Market by Type, Performance - Potential Analysis
5.3. Global Pentavalent Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Pentavalent Market, Sub Segment Analysis
5.4.1. Sodium Stibogluconate
5.4.2. Meglumine Antimoniate
CHAPTER 6. GLOBAL PENTAVALENT MARKET, BY FORMULATION TYPE
6.1. Market Snapshot
6.2. Global Pentavalent Market by Formulation Type, Performance - Potential Analysis
6.3. Global Pentavalent Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
6.4. Pentavalent Market, Sub Segment Analysis
6.4.1. Lyophilized
6.4.2. Liquid
CHAPTER 7. GLOBAL PENTAVALENT MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Pentavalent Market by Application, Performance - Potential Analysis
7.3. Global Pentavalent Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Pentavalent Market, Sub Segment Analysis
7.4.1. Hospitals Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
CHAPTER 8. GLOBAL PENTAVALENT MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Pentavalent Market, Regional Market Snapshot
8.4. North America Pentavalent Market
8.4.1. U.S. Pentavalent Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Formulation Type breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Pentavalent Market
8.5. Europe Pentavalent Market Snapshot
8.5.1. U.K. Pentavalent Market
8.5.2. Germany Pentavalent Market
8.5.3. France Pentavalent Market
8.5.4. Spain Pentavalent Market
8.5.5. Italy Pentavalent Market
8.5.6. Rest of Europe Pentavalent Market
8.6. Asia-Pacific Pentavalent Market Snapshot
8.6.1. China Pentavalent Market
8.6.2. India Pentavalent Market
8.6.3. Japan Pentavalent Market
8.6.4. Australia Pentavalent Market
8.6.5. South Korea Pentavalent Market
8.6.6. Rest of Asia Pacific Pentavalent Market
8.7. Latin America Pentavalent Market Snapshot
8.7.1. Brazil Pentavalent Market
8.7.2. Mexico Pentavalent Market
8.8. Middle East & Africa Pentavalent Market
8.8.1. Saudi Arabia Pentavalent Market
8.8.2. South Africa Pentavalent Market
8.8.3. Rest of Middle East & Africa Pentavalent Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Sanofi
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. GlaxoSmithKline PLC.
9.3.3. Bristol-Myers Squibb Company
9.3.4. Maiden Pharmaceuticals Limited
9.3.5. Shandong Xinhua Pharmaceutical Co.,Ltd.
9.3.6. Panacea Biotec Ltd.
9.3.7. Biological E. Ltd.
9.3.8. Novartis AG
9.3.9. Shantha Biotechnics Ltd.
9.3.10. Serum Institute of India Pvt. Ltd.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Pentavalent Market, report scope
TABLE 2. Global Pentavalent Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Pentavalent Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Pentavalent Market estimates & forecasts by Formulation Type 2020-2030 (USD Billion)
TABLE 5. Global Pentavalent Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 6. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Pentavalent Market
TABLE 71. List of primary sources, used in the study of global Pentavalent Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Pentavalent Market, report scope
TABLE 2. Global Pentavalent Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Pentavalent Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Pentavalent Market estimates & forecasts by Formulation Type 2020-2030 (USD Billion)
TABLE 5. Global Pentavalent Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 6. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Pentavalent Market
TABLE 71. List of primary sources, used in the study of global Pentavalent Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Pentavalent Market, research methodology
FIG 2. Global Pentavalent Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Pentavalent Market, key trends 2022
FIG 5. Global Pentavalent Market, growth prospects 2023-2030
FIG 6. Global Pentavalent Market, porters 5 force model
FIG 7. Global Pentavalent Market, pest analysis
FIG 8. Global Pentavalent Market, value chain analysis
FIG 9. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Pentavalent Market, regional snapshot 2020 & 2030
FIG 15. North America Pentavalent Market 2020 & 2030 (USD Billion)
FIG 16. Europe Pentavalent Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Pentavalent Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Pentavalent Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Pentavalent Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Pentavalent Market, research methodology
FIG 2. Global Pentavalent Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Pentavalent Market, key trends 2022
FIG 5. Global Pentavalent Market, growth prospects 2023-2030
FIG 6. Global Pentavalent Market, porters 5 force model
FIG 7. Global Pentavalent Market, pest analysis
FIG 8. Global Pentavalent Market, value chain analysis
FIG 9. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Pentavalent Market, regional snapshot 2020 & 2030
FIG 15. North America Pentavalent Market 2020 & 2030 (USD Billion)
FIG 16. Europe Pentavalent Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Pentavalent Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Pentavalent Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Pentavalent Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
